NAFLD and Cardiovascular Risk: Direct Evidence for the Tale of Two Ages

被引：10

作者：

Lonardo, Amedeo ^{[1
]}

Loria, Paola ^{[1
]}

机构：

[1] Univ Modena & Reggio Emilia, Dept Internal Med Endocrinol Metab & Geriatr, Nuovo Osped St Agostino Estense, I-41100 Modena, Italy

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2009年 / 104卷 / 07期

关键词：

FATTY LIVER-DISEASE;

D O I：

10.1038/ajg.2009.233

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1851 / 1852

页数：3

共 50 条

[21] Increased risk of cardiovascular disease and chronic kidney disease in NAFLD
Bonora, Enzo
Targher, Giovanni
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2012, 9 (07) : 372 - 381
[22] The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular Risk
Cyrielle Caussy
Adrien Aubin
Rohit Loomba
Current Diabetes Reports, 2021, 21
[23] Increased risk of cardiovascular disease and chronic kidney disease in NAFLD
Enzo Bonora
Giovanni Targher
Nature Reviews Gastroenterology & Hepatology, 2012, 9 : 372 - 381
[24] The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular Risk
Caussy, Cyrielle
Aubin, Adrien
Loomba, Rohit
CURRENT DIABETES REPORTS, 2021, 21 (05)
[25] Metabolic NAFLD subtypes align with cardiovascular and genetic risk factors
Martinez-Arranz, Ibon
Bruzzone, Chiara
Noureddin, Mazen
Gil-Redondo, Ruben
Arretxe, Enara
Iruarrizaga-Lejarreta, Marta
Bizkarguenaga, Maider
Minchole, Itziar
Fernandez Ramos, David
Lopitz Otsoa, Fernando
Mayo, Rebeca
Embade, Nieves
Newberry, Elizabeth
Mittendorf, Bettina
Izquierdo-Sanchez, Laura
Perez Castano, Ylenia
Smid, Vaclav
Arnold, Jorge
Krawczyk, Marcin
Iruzubieta, Paula
Marigorta, Urko M.
Morrison, Martine C.
Kleemann, Robert
Duce, Antonio Martin
Hayardeny, Liat
Vitek, Libor
Bruha, Radan
Aller, Rocio
Crespo, Javier
Romero Gomez, Manuel
Maria Banales, Jesus
Arrese, Marco
Cusi, Kenneth
Bugianesi, Elisabetta
Klein, Samuel
Lu, Shelly C.
Anstee, Quentin
Millet, Oscar
Davidson, Nicholas O.
Alonso, Cristina
Mato, Jose M.
JOURNAL OF HEPATOLOGY, 2022, 77 : S671 - S672
[26] Noninvasive tool for the diagnosis of NAFLD in association with atherosclerotic cardiovascular risk
Musa N.I.
Safwat E.
Abdelhakam S.M.
Farid A.M.
Hetta W.M.
Egyptian Liver Journal, 9 (1)
[27] IS THERE A FAIRY TALE MATRIX IN INFERNO I? OR: MARCHEN IN THE MIDDLE AGES - ABSENCE OF EVIDENCE OR EVIDENCE OF ABSENCE?
Meyer, Ole
I LUOGHI NOSTRI: DANTE'S NATURAL AND CULTURAL SPACES, 2015, : 85 - 105
[28] Fibroscan® Results Do Not Correlate with Cardiovascular Risk Assessment in NAFLD Patients
Lombardi, Rosa
Petta, Salvatore
Giannetti, Aurora
Boemi, Roberta
Pisano, Giuseppina
Bertelli, Cristina
Craxi, Antonio
Fargion, Silvia
Fracanzani, Anna Ludovica
HEPATOLOGY, 2018, 68 : 964A - 965A
[29] NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment
Targher, Giovanni
Corey, Kathleen E.
Byrne, Christopher D.
DIABETES & METABOLISM, 2021, 47 (02)
[30] Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles
Martinez-Arranz, Ibon
Bruzzone, Chiara
Noureddin, Mazen
Gil-Redondo, Ruben
Minchole, Itziar
Bizkarguenaga, Maider
Arretxe, Enara
Iruarrizaga-Lejarreta, Marta
Fernandez-Ramos, David
Lopitz-Otsoa, Fernando
Mayo, Rebeca
Embade, Nieves
Newberry, Elizabeth
Mittendorf, Bettina
Izquierdo-Sanchez, Laura
Smid, Vaclav
Arnold, Jorge
Iruzubieta, Paula
Perez Castano, Ylenia
Krawczyk, Marcin
Marigorta, Urko M.
Morrison, Martine C.
Kleemann, Robert
Martin-Duce, Antonio
Hayardeny, Liat
Vitek, Libor
Bruha, Radan
Aller de la Fuente, Rocio
Crespo, Javier
Romero-Gomez, Manuel
Banales, Jesus M.
Arrese, Marco
Cusi, Kenneth
Bugianesi, Elisabetta
Klein, Samuel
Lu, Shelly C.
Anstee, Quentin M.
Millet, Oscar
Davidson, Nicholas O.
Alonso, Cristina
Mato, Jose M.
HEPATOLOGY, 2022, 76 (04) : 1121 - 1134

← 1 2 3 4 5 →